SE0401942D0 - New antimicrobial peptide complexes - Google Patents

New antimicrobial peptide complexes

Info

Publication number
SE0401942D0
SE0401942D0 SE0401942A SE0401942A SE0401942D0 SE 0401942 D0 SE0401942 D0 SE 0401942D0 SE 0401942 A SE0401942 A SE 0401942A SE 0401942 A SE0401942 A SE 0401942A SE 0401942 D0 SE0401942 D0 SE 0401942D0
Authority
SE
Sweden
Prior art keywords
antimicrobial peptide
peptide complexes
new antimicrobial
charged peptide
complexes
Prior art date
Application number
SE0401942A
Other languages
English (en)
Inventor
Anders Carlsson
Conny Bogentoft
Mona Staahle
Johan Heiborn
Original Assignee
Lipopeptide Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipopeptide Ab filed Critical Lipopeptide Ab
Priority to SE0401942A priority Critical patent/SE0401942D0/sv
Publication of SE0401942D0 publication Critical patent/SE0401942D0/sv
Priority to AU2005215364A priority patent/AU2005215364A1/en
Priority to EP05711112A priority patent/EP1722822A1/en
Priority to JP2007500715A priority patent/JP2007523211A/ja
Priority to CA002556690A priority patent/CA2556690A1/en
Priority to US10/590,548 priority patent/US20080058249A1/en
Priority to PCT/SE2005/000252 priority patent/WO2005079860A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
SE0401942A 2004-02-24 2004-07-28 New antimicrobial peptide complexes SE0401942D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0401942A SE0401942D0 (sv) 2004-07-28 2004-07-28 New antimicrobial peptide complexes
AU2005215364A AU2005215364A1 (en) 2004-02-24 2005-02-23 New complexes
EP05711112A EP1722822A1 (en) 2004-02-24 2005-02-23 New complexes
JP2007500715A JP2007523211A (ja) 2004-02-24 2005-02-23 新規な複合体
CA002556690A CA2556690A1 (en) 2004-02-24 2005-02-23 New complexes
US10/590,548 US20080058249A1 (en) 2004-02-24 2005-02-23 Complexes
PCT/SE2005/000252 WO2005079860A1 (en) 2004-02-24 2005-02-23 New complexes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0401942A SE0401942D0 (sv) 2004-07-28 2004-07-28 New antimicrobial peptide complexes

Publications (1)

Publication Number Publication Date
SE0401942D0 true SE0401942D0 (sv) 2004-07-28

Family

ID=32867303

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0401942A SE0401942D0 (sv) 2004-02-24 2004-07-28 New antimicrobial peptide complexes

Country Status (7)

Country Link
US (1) US20080058249A1 (sv)
EP (1) EP1722822A1 (sv)
JP (1) JP2007523211A (sv)
AU (1) AU2005215364A1 (sv)
CA (1) CA2556690A1 (sv)
SE (1) SE0401942D0 (sv)
WO (1) WO2005079860A1 (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5688293B2 (ja) * 2007-12-21 2015-03-25 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ ペプチドを含有するフケ防止組成物
US9908925B2 (en) 2011-10-27 2018-03-06 Case Western Reserve University Ultra-concentrated rapid-acting insulin analogue formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
AU691249B2 (en) * 1994-02-04 1998-05-14 Lipocore Holding Ab Bilayer preparations
ZA96525B (en) * 1995-02-06 1996-08-06 Astra Ab Novel pharmaceutical compositions
AU6793598A (en) * 1997-03-31 1998-10-22 University Of Iowa Research Foundation, The Glycosylceramide-containing liposomes
US6306433B1 (en) * 1997-08-12 2001-10-23 Pharmacia Ab Method of preparing pharmaceutical compositions
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
SE9804192D0 (sv) * 1998-12-03 1998-12-03 Scotia Lipidteknik Ab New formulation
SE0300207D0 (sv) * 2003-01-29 2003-01-29 Karolinska Innovations Ab New use and composition

Also Published As

Publication number Publication date
EP1722822A1 (en) 2006-11-22
AU2005215364A1 (en) 2005-09-01
CA2556690A1 (en) 2005-09-01
JP2007523211A (ja) 2007-08-16
WO2005079860A1 (en) 2005-09-01
US20080058249A1 (en) 2008-03-06

Similar Documents

Publication Publication Date Title
CU23367A3 (es) Formulación de moxifloxacino con sal común
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
CY1116463T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
EA200601777A1 (ru) Новое применение пептидных соединений для лечения боли при болезненной диабетической нейропатии
WO2005089738A3 (en) Use and administration of bacterial efflux pump inhibitors
WO2012017349A3 (en) Topical pharmaceutical composition comprising nanonized silver sulfadiazine and chlorhexidine gluconate
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
WO2006085932A3 (en) Anti-viral uses of borinic acid complexes
BR112015025805A2 (pt) compostos de ligação de nh3 e métodos para inibir o transporte de fosfato
DE60123100D1 (de) Honig enthaltende pharmazeutische zusammensetzung zur wundbehandlung
EA202090637A1 (ru) Способы применения дипивефрина
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2015001019A (es) Preparacion para tratamiento de heridas y llagas que comprende hipoclorito y aminoacidos.
DE60312969D1 (de) Zubereitung für die wundheilung und zur verhinderung des anhaftens von verbänden an die wunde
DE60320034D1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
CY1106950T1 (el) Μονοενυδρο αλας νατριου της s-tενατοπραζολης και εφαρμογη υπο τυπον αναστολεα αντλιας πρωτονιων
SE0401942D0 (sv) New antimicrobial peptide complexes
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
TW200610530A (en) Anti-parasitic uses of borinic acid complexes
BRPI0918593A2 (pt) composição farmacêutica para uso no tratamento de infecções transmitidas sexualmente
SE0300535D0 (sv) Treatment of burns
CY1108472T1 (el) Μεθοδος για θεραπεια βακτηριακων μολυνσεων με χρηση γεμιφλοξακινης ή ενος αλατος αυτης και ενα αντιβακτηριακο παραγοντα καρβαπενεμης
RU2006104187A (ru) Препарат для лечения микозов и гнойной инфекции